Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Asthma
On September 16, 2021, ICER released its draft evidence report, “Tezepelumab for Severe Asthma: Effectiveness and Value.” This guide provides a framework for considering what aspects of the new treatment for asthma are important to patients and their families, and how...Read more